Hospitalization rates from respiratory syncytial virus (RSV) infection rose with age. Also, hospitalizations were more likely among nursing home residents and older adults with other health issues, ...
Hosted on MSN8d
RSV hospitalization risk among older adults linked to age and certain risk conditionsAmong older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively ...
In primary care settings, the burden of RSV on young children and their guardians often varied between the countries of ...
Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...
Total company revenue fell from a peak of $19.3 billion in 2022 to $3.2 billion for the full year ended Dec. 31, 2024. For ...
The Parainfluenza Virus Infection market is expected to surge due to the disease's increasing prevalence and awareness during ...
A study from Yale University today in JAMA Network Open reveals substantial protection by the preventive drug nirsevimab ...
A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.
Health officials say strep is 'a bacterial infection that causes several symptoms like sore throat, red tonsils, headaches, ...
Coinfection with RSV, REV, and MPV was significantly associated with treatment failure and prolonged treatment in children with viral LRTIs on respiratory support.
More Alberta seniors are now eligible for provincially funded RSV vaccines. All Albertans 70 and over are now eligible.
A newly released white paper, based on research conducted independently by IQVIA, a global healthcare consultancy, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results